Although chemotherapy drugs are extensively utilized in cancer therapy, their administration
for treatment of patients has faced problems that regardless of chemoresistance, increasing …

Doxorubicin (DOX) is one of the most effective anticancer drugs to treat various forms of
cancers; however, its therapeutic utility is severely limited by its associated cardiotoxicity …

Cardiotoxicity is the main side effect of several chemotherapeutic drugs. Doxorubicin (Doxo)
is one of the most used anthracyclines in the treatment of many tumors, but the development …

Doxorubicin (DOX) is a cytostatic antibiotic from the class of anthracyclines widely used in
chemotherapeutic cancer treatments. Despite the efficiency against several types of cancer …

Doxorubicin is an extensively used anti-neoplastic drug used for solid and hematogenous
cancer since the 1950s, and its usage is limited due to its toxic effects upon various organs …

Doxorubicin (Dox) is a secondary metabolite of the mutated strain of Streptomyces peucetius
var. Caesius and belongs to the anthracyclines family. The anti-cancer activity of Dox is …

Doxorubicin (DOX), despite being an effective anti-cancer drug has offsite targets that affect
the vital organs such as heart, brain and kidney. DOX-induced cardiotoxicity is reported as a …

Cancer is a destructive disease that causes high levels of morbidity and mortality.
Doxorubicin (DOX) is a highly efficient antineoplastic chemotherapeutic drug, but its use …

Background As an anthracycline antibiotic, doxorubicin (DOX) is one of the most potent and
widely used chemotherapeutic agents for various types of solid tumors. Unfortunately …

Doxorubicin (Dox) is among the most widely used cancer chemotherapeutic drugs. The
clinical use of Dox is, however, limited due to its cardiotoxicity. Studies over the past several …